Frédéric Collin

Frédéric Collin

Auto-generated profile, based on publicly available information

Frédéric Collin

Department of Biological Chemistry, John Innes Centre, Norwich Research Park, Norwich, NR4 7UH United Kingdom

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 September 2011 in Applied Microbiology and Biotechnology
Verified
Journal Article
Open access
PDF file
FCFrédéric Collin
Frédéric Collin
SKShantanu Karkare
Shantanu Karkare
AMAnthony Maxwell
Anthony Maxwell
DNA gyrase is a type II topoisomerase that can introduce negative supercoils into DNA at the expense of ATP hydrolysis. It is essential in all bacteria but absent from higher eukaryotes, making it an attractive target for antibacterials. The fluoroquinolones are examples of very successful gyrase-targeted drugs, but the rise in bacterial resistance to these agents means that we not only need to seek new compounds, but also new modes of inhibition of this enzyme. We review known gyrase-specific drugs and toxins and assess the prospects for developing new antibacterials targeted to this enzyme.

1 February 2013 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
SKShantanu Karkare
Shantanu Karkare
TCTerence T. H. Chung
Terence T. H. Chung
FCFrederic Collin
Frederic Collin
LMLesley A. Mitchenall
Lesley A. Mitchenall
AMAdam R. McKay
Adam R. McKay
AMAnthony Maxwell
Anthony Maxwell
Tuberculosis and other bacterial diseases represent a significant threat to human health. The DNA topoisomerases are excellent targets for chemotherapy, and DNA gyrase in particular is a well-validated target for antibacterial agents. Naphthoquinones (e.g. diospyrin and 7-methyljuglone) have been shown to have therapeutic potential, particularly against Mycobacterium tuberculosis. We have found that these compounds are inhibitors of the supercoiling reaction catalyzed by M. tuberculosis gyrase and other gyrases. Our evidence strongly suggests that the compounds bind to the N-terminal domain of GyrB, which contains the ATPase active site, but are not competitive inhibitors of the ATPase reaction. We propose that naphthoquinones bind to GyrB at a novel site close to the ATPase site. This novel mode of action could be exploited to develop new antibacterial agents.

10 April 2013 in PLOS ONE
Verified
Journal Article
Open access
PDF file
FCFrédéric Collin
Frédéric Collin
RTRobert E. Thompson
Robert E. Thompson
KJKatrina Jolliffe
Katrina Jolliffe
RPRichard J. Payne
Richard J. Payne
AMAnthony Maxwell
Anthony Maxwell
Fluoroquinolones are very important drugs in the clinical antibacterial arsenal; their success is principally due to their mode of action: the stabilisation of a gyrase-DNA intermediate (the cleavage complex), which triggers a chain of events leading to cell death. Microcin B17 (MccB17) is a modified peptide bacterial toxin that acts by a similar mode of action, but is unfortunately unsuitable as a therapeutic drug. However, its structure and mechanism could inspire the design of new antibacterial compounds that are needed to circumvent the rise in bacterial resistance to current antibiotics. Here we describe the investigation of the structural features responsible for MccB17 activity and the identification of fragments of the toxin that retain the ability to stabilise the cleavage complex.

1 June 2015 in Tuberculosis
Verified
Journal Article
Closed access
ASAnna Sipos
Anna Sipos
JPJános Pató
János Pató
RSRita Székely
Rita Székely
RHRuben C Hartkoorn
Ruben C Hartkoorn
LKLászló Kékesi
László Kékesi
GKGyörgy Kéri
György Kéri

14 January 2014 in Organic & Biomolecular Chemistry
Verified
Journal Article
Closed access
PDF file
RTRobert E. Thompson
Robert E. Thompson
FCFrédéric Collin
Frédéric Collin
AMAnthony Maxwell
Anthony Maxwell
KJKatrina Jolliffe
Katrina Jolliffe
RPRichard J. Payne
Richard J. Payne
Using a combination of solid-phase peptide synthesis and fragment assembly strategies a library of full-length and truncated analogues of the antibacterial post-translationally modified peptide microcin B17 have been synthesised. Both antibacterial and DNA gyrase poisoning activities are also described for the synthetic analogues.